Barclays analyst Steve Valiquette downgrades Bright Health Gr (NYSE:BHG) from Overweight to Underweight and raises the price target from $4 to $8.
Barclays Downgrades Bright Health Gr to Underweight, Raises Price Target to $8
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.